+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

DelveInsight - Market Research Reports

Delve Insight authors market leading reports across the pharmaceutical and biotechnology sectors. The key findings and insights all come from regular monitoring of developments through the pharmaceutical and biotechnology sectors. These findings are then published through market forecasts, drug pipelines and drug insights, along with advice from top market analysts on how to best use this, alongside the detailed market forecasts offered by Delve Insight.

Cold Agglutinin Disease- Pipeline Insight, 2025 - Product Thumbnail Image

Cold Agglutinin Disease- Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Colorectal Cancer - Pipeline Insight, 2025 - Product Thumbnail Image

Colorectal Cancer - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 550 Pages
  • Global
From
Common Cold - Pipeline Insight, 2025 - Product Thumbnail Image

Common Cold - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Common Warts - Pipeline Insight, 2025 - Product Thumbnail Image

Common Warts - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Community-Acquired Bacterial Pneumonia (CABP) - Pipeline Insight, 2025 - Product Thumbnail Image

Community-Acquired Bacterial Pneumonia (CABP) - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Cone Rod Dystrophy - Pipeline Insight, 2025 - Product Thumbnail Image

Cone Rod Dystrophy - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Corneal Ulcer - Pipeline Insight, 2025 - Product Thumbnail Image

Corneal Ulcer - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 50 Pages
  • Global
From
Coronary Occlusion (Includes CAD Also) - Pipeline Insight, 2025 - Product Thumbnail Image

Coronary Occlusion (Includes CAD Also) - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Corticobasal Degeneration (CBD) - Pipeline Insight, 2025 - Product Thumbnail Image

Corticobasal Degeneration (CBD) - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Cryptococcal Meningitis - Pipeline Insight, 2025 - Product Thumbnail Image

Cryptococcal Meningitis - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Cutaneous Lupus Erythematosus- Pipeline Insight, 2025 - Product Thumbnail Image

Cutaneous Lupus Erythematosus- Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Cutaneous T-cell Lymphoma - Pipeline Insight, 2025 - Product Thumbnail Image

Cutaneous T-cell Lymphoma - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 80 Pages
  • Global
From
From
Cystinosis- Pipeline Insight, 2025 - Product Thumbnail Image

Cystinosis- Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Cystinuria - Pipeline Insight, 2025 - Product Thumbnail Image

Cystinuria - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Cytomegalovirus Infection - Pipeline Insight, 2025 - Product Thumbnail Image

Cytomegalovirus Infection - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 80 Pages
  • Global
From
Deep Partial-Thickness Thermal Burns - Pipeline Insight, 2025 - Product Thumbnail Image

Deep Partial-Thickness Thermal Burns - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Hidradenitis Suppurativa - Pipeline Insight, 2025 - Product Thumbnail Image

Hidradenitis Suppurativa - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 115 Pages
  • Global
From
Dermatomyositis - Pipeline Insight, 2025 - Product Thumbnail Image

Dermatomyositis - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
HR Positive/ HER2 Negative Breast Cancer- Pipeline Insight, 2025 - Product Thumbnail Image

HR Positive/ HER2 Negative Breast Cancer- Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 180 Pages
  • Global
From
Loading Indicator